Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (14678)	2/11/1998 10:10:00 PM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

TD, I don't expect that big of a move because LGND is more mature and has more outstanding shares. Tomorrow's initial move is dependent on coverage. I expect CNBC to cover them a few times before the open and on winners and losers during the day. If WSJ, USA Today, or NY Times run a story, then I would look for a 2 point jump. Without them, I would say 1-2 points. Without CNBC, I would say 1 point or less. I actually would rather see a gradual rise. LGND keeps on firing away with data and I would much rather see long term buyers than day traders. They make for lots of excitement but too much oscillation. It's time for LGND to begin a sustained move higher. It's not bravado - I still think that I have a shot (somewhat long) of getting one of the wine bottles back (in the summer, not the spring).

To: Arthur Radley who wrote (14678)	2/11/1998 10:45:00 PM
From: Andrew H	Respond to of 32384

>>Trying to anticipate the action tomorrow in LGND stock, if we draw a parallel to Entremed(ENMD), we should expect a real "pop" in the stock. If you recall, back in December ENMD announced pre-clinical rat results and their stock ran from around 10.00 to 16.75. ENMD is a one product(potential)company and we all know the pipeline and imminent NDA's that LGND is ready to file. Don't you think that LGND should do as well as ENMD considering the far greater potential?<< TD, let's not get the cavalry out too soon--remember ENMD had a much smaller market cap, so the price runup is really not comparable. Plus, they were rather unethically suggesting a cure for all tumors.

To: Arthur Radley who wrote (14678)	2/12/1998 12:52:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

>Trying to anticipate the action tomorrow in LGND stock, if we draw a >parallel to Entremed(ENMD), we should expect a real "pop" in the >stock. If you recall, back in December ENMD announced pre-clinical >rat results and their stock ran from around 10.00 to 16.75. ENMD is a >one product(potential)company and we all know the pipeline >and imminent NDA's that LGND is ready to file. Don't you think that >LGND should do as well as ENMD considering the far greater potential? Maybe we should all be careful about raising expectations too much before the market has spoken. A number of us agree that LGND has tremendous value. But that may or may not be reflected on the tape right away. I would settle for a point or two for now and take the rest in installments. Actually, if any of you - like Tony - feel like selling some at 13 or so in the morning, I think I would like to buy some..... Cheers, Torben P.S. Right now, I feel pretty good about having margined myself fairly heavily buying LGNDW at 5.5. I was going to sell off some more LGND to reduce my margin level, but I just couldn't bring myself to part with it :-)